Session » Systemic Lupus Erythematosus - Human Etiology and Pathogenesis II: Pathogenic Targets, Genetic Variants and Apoptosis
-
Abstract Number: 2839
BCL-2 As a Potential Therapeutic Target in Human Lupus Tubulointerstitial Inflammation
-
Abstract Number: 2840
Targeting the RhoA-Rock Pathway to Reverse T Cell Dysfunction in SLE
-
Abstract Number: 2841
Identifying Novel Lupus Severity Risk Variants through Identification of Alleles with High Ethnic Variability Worldwide